JOGO Health is a clinical stage digital therapeutics company that has developed a platform using biosensors and therapeutic applications/games with indications for stroke, chronic pain, urinary/fecal incontinence, cerebral palsy, post orthopedic recovery, pain in cancer patients and premature ejaculation using the proven science of biofeedback and neuroplasticity. JOGO results have been peer-reviewed by JAMA, American Congress of Rehabilitation Medicine(ACRM) , Australia New Zealand Spinal Cord Society(ANZSCoS), Clinical Orthopedic Society(COS) and Neurological Disorders Summit (NDS). JOGO research originated out of NYU and Manhattan College. Phase 3 trials are underway for three conditions. Co-Founder has a track of record of building health tech companies. His previous venture, an AI powered drug safety platform was acquired by IQVIA, world's largest clinical research organization. Advisory board is from Yale, NYU, Boston University. JOGO is currently in JLABS incubator at UPenn.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):